Latest Blog Posts Tagged "Gene Therapy"
December 21, 2018
Several trials recently took steps forward to advance new therapies that could slow or stop Parkinson's progression and treat movement and non-movement symptoms.
September 06, 2017
Voyager Therapeutics today announced positive interim results from an ongoing trial testing a gene therapy that helps the brain make dopamine from levodopa.
December 08, 2016
Voyager Therapeutics announced results from a trial, supported in early stages by MJFF, to help the brain convert levodopa to dopamine and better control motor symptoms.
ProSavin Trial Results: Once Again, a Gene Therapy Approach to Parkinson's Yields Encouraging Safety Data but Modest Efficacy
January 28, 2014
Raymond T. Bartus, PhD, talks to FoxFeed about the results of a safety study testing a gene therapy approach to treat the motor symptoms of Parkinson's disease.
May 14, 2013
The projects from the University of California San Francisco and the biotech Genzyme are focused on the depletion of an enzyme called AADC.
Novel Partnership between Academia and Industry Drives Forward Gene Therapy Approach to Treat Parkinson's
March 13, 2013
Head of the Sanofi Genzyme R&D Center Rich Gregory, PhD, tells MJFF how his company is developing a critical research tool for use in a clinical trial at the University of California San Francisco.
July 20, 2012
According to a report in today's New York Times, the European Medicines Agency has recommended that gene therapy be approved for use in a rare disease called lipoprotein lipase deficiency.
Ceregene: Early Indications that Trophic Factor Biochemically Active in Brain Long After Gene Therapy; More Research Needed
June 05, 2012
Biotech company Ceregene announced evidence of increased levels of the trophic factor neurturin in the brain, for four-plus years following CERE-120 gene therapy to treat Parkinson's disease.